Viewing nowAtorotin Tablet (Atorvastatin Calcium)
Atorvastatin Calcium 10.36mg
Tablet · Prescription medication
Samsung Pharmaceutical Co., Ltd.

MFDS item code 201307661 · Approved 2013.06.11 · Insurance code 642306280
Improvement of hyperlipidemia and prevention of cardiovascular diseases (such as myocardial infarction and stroke)
This medication helps reduce the risk of cardiovascular diseases. In particular, it decreases the risk of myocardial infarction, stroke, and angina in adults with cardiovascular disease risk factors or those with type 2 diabetes. It is also effective in reducing the risk of hospitalization due to myocardial infarction, stroke, or congestive heart failure in patients who already have coronary artery disease. In patients with dyslipidemia, it lowers total cholesterol and LDL cholesterol levels while raising HDL cholesterol levels, thereby improving blood lipid profiles. Particularly, it is used for treating pediatric patients with familial hypercholesterolemia conforming to specific criteria. Therefore, this medication is used effectively to improve cardiovascular diseases and dyslipidemia.
Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. This medication may be taken at any time of day, with or without food. Hyperlipidemia: The recommended initial dose is 10 mg of atorvastatin once daily; however, for patients requiring a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medication is administered at doses ranging from 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to patient characteristics, taking treatment goals and response into account. Lipid levels should be analyzed within 2 ~ 4 weeks of starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, LDL cholesterol is recommended for use when initiating treatment and evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia: The dose of this medication is 10 ~ 80 mg once daily. It may be administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. Patients with renal impairment: Renal disease does not affect atorvastatin plasma concentrations or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. Elderly patients: Efficacy and safety in patients aged 70 years or older are generally similar to those in adult patients.
Pediatric patients aged 10 ~ 17 years with heterozygous familial hypercholesterolemia: The recommended initial dose is 10 mg of this medication once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses of this medication higher than 20 mg in pediatric patients).
This medication may cause abnormal muscle symptoms, so if severe muscle pain or weakness occurs, discontinue use immediately and consult a doctor. Patients with active liver disease or severely impaired liver function should not use this medication. Women who are pregnant, may become pregnant, or are breastfeeding should not take this medication. Patients who cannot digest lactose due to certain genetic disorders should not use this medication. This medication is not administered to children, especially those under 10 years of age. Patients with liver or kidney issues must consult a doctor before taking this medication and require regular monitoring while on it. Since it may interact with other medications, it's important to inform your doctor or pharmacist of any other medications currently being taken. This medication can affect liver function, so regular liver function tests should be conducted before and during treatment. If allergic reactions such as rash, hives, itching, or difficulty breathing occur during treatment, discontinue use immediately and inform medical staff. In case of overdose, there is no specific antidote, so appropriate treatment should be provided based on symptoms, and liver function and muscle condition should be monitored. It is advisable to avoid alcohol while on this medication, and regular medical check-ups should be scheduled for safe administration. Store out of reach of children and keep in the original container to prevent misuse or degradation of quality.
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly sealed container to prevent exposure to air or moisture. Additionally, to maintain the effectiveness of the drug, it is important to store it at room temperature between 1°C and 30°C.
White oval film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium 10.36mg
Tablet · Prescription medication
Samsung Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.